Last edition
News about "Pharmaceutical Acquisition"
Sun Pharma Acknowledges Organon Shareholder Approval for Acquisition
Sun Pharma has acknowledged Organon shareholders' approval of the proposed acquisition, marking a key milestone toward completion of the transaction.
Pharmaceutical Acquisition | 24/07/2026 | By News Bureau | 167
AbbVie to Acquire Apogee Therapeutics
AbbVie plans to acquire Apogee Therapeutics, expanding its immunology portfolio with a diverse pipeline of innovative therapies for dermatologic, respiratory, inflammatory, and immune-mediated diseases.
Pharmaceutical Acquisition | 23/06/2026 | By News Bureau
Assertio Announces Completion of Merger with Zydus Lifesciences
Assertio has completed its merger with Zydus Lifesciences, becoming a wholly owned subsidiary of the company. Following the acquisition, Assertio shares have been delisted from Nasdaq, with shareholders receiving USD 23.50 per share in cash.
Pharmaceutical Acquisition | 19/06/2026 | By News Bureau | 106
Teva Completes Acquisition of Emalex Biosciences
Teva has completed its acquisition of Emalex Biosciences, strengthening its late-stage neuroscience pipeline. The deal supports Teva’s Pivot to Growth strategy.
Pharmaceutical Acquisition | 12/06/2026 | By News Bureau | 155
Asahi Kasei expands its global pharmaceutical footprint with the acquisition of Aicuris, strengthening its pipeline in infectious diseases and advancing treatments for immunocompromised patients.
Pharmaceutical Acquisition | 21/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy